Related by context. All words. (Click for frequent words.) 76 Dasatinib 73 Gleevec resistant 73 Gefitinib 73 Bevacizumab 71 Bortezomib 71 imatinib Gleevec 71 Nilotinib 70 Erlotinib 70 imatinib 70 Fludarabine 70 Pertuzumab 69 Rituximab 69 Trastuzumab 69 Anthracycline 69 Disease Progression 69 gastrointestinal stromal tumors GIST 69 imatinib Gleevec ® 69 AMN# [001] 69 Everolimus 69 Cetuximab 69 Alemtuzumab 69 dasatinib Sprycel 69 Azacitidine 69 imatinib resistance 69 Docetaxel 68 Irinotecan 68 Aliskiren 68 EGFR inhibitors 68 Pegylated 68 Raltegravir 68 Bosutinib 68 Hydroxyurea 68 proteasome inhibitors 68 Lenalidomide 68 Novartis Gleevec 67 Fulvestrant 67 Monotherapy 67 Sorafenib 67 Gemcitabine 67 DFMO 67 Adalimumab 67 Crizotinib 67 erlotinib Tarceva ® 67 imatinib therapy 67 Cisplatin 67 dasatinib 67 Exemestane 67 Infliximab 67 Herceptin trastuzumab 67 Darunavir 67 T#I [002] 67 Decitabine 67 Bosentan 66 angiogenesis inhibitor 66 Efficacious 66 EGFR TKI 66 gefitinib Iressa 66 nilotinib 66 Fluorouracil 66 Fingolimod 66 lapatinib Tykerb 66 decitabine 66 olaparib 66 receptor tyrosine kinase inhibitor 66 Capecitabine 66 metastatic malignant 66 mTOR inhibitor 66 Eltrombopag 66 Anthracyclines 66 imatinib mesylate 66 nucleoside analogue 66 proteasome inhibitor 66 tyrosine kinase inhibitor 66 Epidermal Growth Factor Receptor 66 gastrointestinal stromal tumors 66 EGFr 66 Chronic Myeloid Leukemia 66 Vidofludimus 66 Laquinimod 66 Tumor Necrosis Factor 66 sorafenib Nexavar 66 Myelodysplastic Syndrome MDS 66 fulvestrant 66 Renal Cell Carcinoma 66 alkylating agent 66 bevacizumab Avastin 65 Mipomersen 65 biologic therapy 65 pegfilgrastim 65 Lapatinib 65 Epratuzumab 65 Tocilizumab 65 Naive Patients 65 Xanafide 65 molecularly targeted 65 chemopreventive agent 65 flavopiridol 65 angiotensin converting enzyme inhibitors 65 Anti Tumor Activity 65 Colchicine 65 Ofatumumab 65 Vorinostat 65 Pemetrexed 65 VAPRISOL 65 Melphalan 65 Combination therapy 65 meropenem 65 Epivir 65 PEGylated Fab fragment 65 Pharmacokinetics PK 65 Sapacitabine 65 pan HDAC inhibitor 65 Adjuvant Treatment 65 nucleoside analogues 65 Tacrolimus 65 Maribavir 65 Omacetaxine 65 Tyrosine Kinase Inhibitor 65 Dapagliflozin 65 EGFR tyrosine kinase inhibitors 65 Cytotoxic 65 Cyclophosphamide 65 Boceprevir 65 alkylating agents 65 antiangiogenesis 65 BCR ABL 65 Peginterferon 65 FLT3 65 tigecycline 65 PARP inhibitors 65 Anti Tumor 65 nucleoside analog 65 mycophenolate mofetil 65 trans retinoic acid 65 Zoledronic acid 65 Doxorubicin 65 topotecan 65 Levodopa 64 Gleevec 64 metastatic renal cell carcinoma 64 Anastrozole 64 NNRTIs 64 Lamotrigine 64 alefacept 64 pertuzumab 64 histone deacetylases 64 Abatacept 64 Candesartan 64 Pegylated Interferon 64 Oritavancin 64 Aurora Kinase 64 ACE Inhibitors 64 Anti TNF 64 cediranib 64 MEK inhibitors 64 tyrosine kinase inhibitors 64 Degarelix 64 idarubicin 64 Celecoxib 64 dasatinib Sprycel ® 64 CDK inhibitor 64 thalidomide Thalomid 64 Fluticasone 64 Granulocyte Colony Stimulating Factor 64 mTOR inhibitors 64 Neoadjuvant 64 Vidaza azacitidine 64 adalimumab Humira 64 nilotinib Tasigna 64 Vandetanib 64 bevacizumab Avastin ® 64 imatinib resistant 64 Pazopanib 64 Leukemias 64 ZD# [001] 64 K ras mutations 64 Torisel 64 Lovastatin 64 Cellcept 64 Antitumor Activity 64 chemotherapeutic drug 64 YONDELIS 64 TNF Tumor Necrosis Factor 64 Bcr Abl 64 sunitinib 64 GRASPA ® 64 Topotecan 64 Gleevec imatinib 64 Oxaliplatin 64 Noxafil 64 Cyclooxygenase 2 64 Zolinza 64 GISTs 64 ZOLINZA 64 Antiangiogenic 64 WT1 64 Taxol ® 64 Temsirolimus 64 pharmacokinetic interactions 64 Myelodysplastic Syndromes 64 Vancomycin 64 paricalcitol 64 Golimumab 64 Fluconazole 64 sodium glucose cotransporter 64 protease inhibitor PI 64 Corticosteroids 64 caspofungin 64 Chronic Lymphocytic Leukemia 64 azacitidine 63 Gastrointestinal Stromal Tumors 63 vWF 63 Hormone Refractory Prostate Cancer 63 Chemokine Receptor 63 VEGF receptor 63 multikinase inhibitor 63 dexamethasone Decadron 63 Valsartan 63 tyrosine kinase inhibitors TKIs 63 Telbivudine 63 MAOI 63 colony stimulating factor 63 Cardiotoxicity 63 abiraterone 63 Interferon alfa 63 Enzastaurin 63 Diuretic 63 Lamivudine 63 immunosuppressant drug 63 EGFR mutation 63 polymerase inhibitor 63 Talabostat 63 Combination Therapy 63 Cyclosporin 63 Dalbavancin 63 Meets Primary Endpoint 63 angiotensin receptor blocker ARB 63 cinacalcet 63 Chronic Sinusitis 63 bendamustine 63 GW# [003] 63 pegylated liposomal doxorubicin 63 Itraconazole 63 Traficet EN 63 Romidepsin 63 superficial bladder cancer 63 Protease inhibitors 63 Rosiglitazone 63 Cytarabine 63 erlotinib Tarceva 63 PLX# 63 Relapsed Refractory 63 Mitoxantrone 63 Rivaroxaban 63 cidofovir 63 Cyclosporine 63 Cethromycin 63 Telmisartan 63 Clofarabine 63 p# MAP kinase 63 Losartan 63 Natalizumab 63 Bezielle 63 tocilizumab 63 Hycamtin 63 Radioimmunotherapy 63 Pioglitazone 63 nucleoside reverse transcriptase inhibitor 63 Prolongs Survival 63 Letrozole 63 Methotrexate 63 Zileuton 63 NNRTI 63 Metastatic Colorectal Cancer 63 Interferon Beta 63 Aurora kinase 63 azoles 63 Lacosamide 63 CYT# potent vascular disrupting 63 5 Fluorouracil 63 Anti VEGF 63 Adjuvant Therapy 63 TNFα 63 rhIL 7 63 Angiotensin 63 anti TNF 63 Enzyme Replacement Therapy 63 Eculizumab 63 cetuximab Erbitux R 63 Tumor Growth 63 Factor Receptor 63 PKC# 63 ritonavir boosted 63 Malignant Melanoma 63 Ixabepilone 63 AZT zidovudine Retrovir 63 Pralatrexate 63 Aflibercept 63 BAY #-# 63 BAL# [001] 63 imipenem 63 Fludara ® 63 Moxifloxacin 63 griseofulvin 63 interferon beta therapy 63 tenofovir Viread 63 anti angiogenic agent 63 xanthine oxidase inhibitor 63 hypomethylating agents 63 Bicalutamide 63 Sitagliptin 63 paclitaxel Taxol 63 Vinorelbine 63 Etanercept 63 Investigational Agent 63 leukemic cells 63 LY# [003] 63 Kinase Inhibitor 63 Interferon beta 63 echinocandin 63 HER2 receptor 63 myelofibrosis polycythemia vera 63 Velcade bortezomib 63 Interferon alpha 63 selective modulator 63 Myelofibrosis 63 Taxanes 63 nucleoside analogs 63 Symadex 63 tipifarnib 62 bortezomib Velcade 62 Diffuse Large B 62 Methylnaltrexone 62 complete cytogenetic response 62 Bucindolol 62 Pregabalin 62 KIT mutations 62 pimozide 62 uric acid lowering 62 Tyrosine Kinase Inhibitors 62 Signaling Pathway 62 Ranibizumab 62 Breast Cancer Cells 62 diagnostic biomarker 62 interferon IFN 62 Mg Usa 62 Investigational Compound 62 Follicular Lymphoma 62 enzyme inhibitor 62 Cutaneous T 62 Allogeneic 62 Valcyte 62 Allopurinol 62 TKIs 62 Camptosar ® 62 Castration Resistant Prostate Cancer 62 temsirolimus 62 LY# [002] 62 IFN beta 62 Bendamustine 62 Tigecycline 62 Voreloxin 62 Liposomal 62 ganciclovir 62 Lung Cancer Patients 62 Protease Inhibitors 62 Ocrelizumab 62 NRTIs 62 Tofacitinib 62 leukotriene receptor antagonist 62 cholinesterase inhibitors 62 Is Well Tolerated 62 Elvitegravir 62 Teriflunomide 62 vascular disrupting agents 62 bicalutamide 62 BMS # 62 rituximab Rituxan 62 DHFR 62 Linezolid 62 angiotensin receptor 62 olmesartan 62 artemisinins 62 5FU 62 Autologous Stem Cell Transplantation 62 effector function 62 Gleevec imatinib mesylate 62 Lopinavir 62 adefovir 62 HDAC Inhibitor 62 Ganciclovir 62 Fondaparinux 62 Interferon 62 efalizumab 62 sunitinib Sutent ® 62 bleomycin 62 Pharmacokinetic Study 62 cetuximab 62 Janus kinase 62 Temozolomide 62 IFN α 62 Nitazoxanide 62 azacytidine 62 Posaconazole 62 antibiotics ciprofloxacin 62 Navelbine ® 62 IFNa 62 receptor blocker 62 pegylated interferons 62 EZN 62 PEGylated anti 62 Erythropoietin 62 relapsed ovarian cancer 62 Tipranavir 62 Mg Uk 62 Hypercholesterolemia 62 VEGFR2 62 Tamibarotene 62 heparanase 62 sertraline Zoloft 62 Bisphosphonate 62 Pulmonary Arterial Hypertension 62 Doxil ® 62 Cancidas 62 Treated Patients 62 Denufosol 62 Blinatumomab 62 interferon therapy 62 SERCA2a 62 Sevelamer 62 tyrosine kinase inhibitor TKI 62 histone deacetylase HDAC inhibitors 62 immunosuppressant 62 multitargeted 62 HuLuc# 62 Estrogen Receptor 62 systemic antifungal 62 leukemia ALL 62 chlorambucil 62 DOXIL 62 XYOTAX TM 62 FOLFOX6 62 calcineurin inhibitors 62 cytostatic 62 mRCC 62 Tiotropium 62 relapsed MM 62 Lupus Nephritis 62 anticancer therapies 62 macrolide antibiotics 62 Akt activation 62 riociguat 62 Certolizumab pegol 62 angiotensin receptor blockers ARBs 62 itraconazole 62 chimeric monoclonal antibody 62 fluconazole 62 Cloretazine 62 vinca alkaloids 62 Carboplatin 62 Imiquimod 62 oblimersen 62 Roche Xeloda 62 GIST tumors 62 Abacavir 62 docetaxel chemotherapy 62 PDGFR 62 protein kinase inhibitor 62 SERMs 62 cetuximab Erbitux ® 62 Glucocorticoid 62 JAK2 V#F 62 vorinostat 62 hypoxia inducible factor 62 echinocandins 62 mapatumumab 62 biliary tract cancer 62 INTEGRILIN R 62 anticancer therapy 62 Preclinical Data 62 Pfizer Sutent 62 BRAF inhibitors 61 Previously Untreated 61 Montelukast 61 cilengitide 61 dihydrofolate reductase 61 Well Tolerated 61 TNFa 61 immunomodulator 61 beta lactam antibiotic 61 Metastatic 61 Vincristine 61 Patients Treated With 61 Cabazitaxel 61 Rilonacept 61 anti TNFs 61 Sym# 61 Upregulation 61 Receptor Antagonists 61 Improved Survival 61 Gene Mutation 61 CCR5 antagonist 61 CYP#A# inhibitors 61 ACE Inhibitor 61 gemcitabine Gemzar 61 cis retinoic acid 61 Fibrinogen 61 Paraplatin ® 61 small molecule tyrosine 61 Demonstrated Significant 61 ara C 61 Octreotide 61 Desmopressin 61 Clusterin 61 Panzem 61 Valproic acid 61 Sipuleucel T 61 relapsed ALL 61 etoposide 61 posaconazole 61 Lung Cancer Survival 61 antiproliferative effects 61 Aptamer 61 Trabectedin 61 eosinophilic asthma 61 immunotoxin 61 leukemia AML 61 Minocycline 61 tipranavir 61 Leucovorin 61 Epoetin Alfa 61 IL 1ß 61 trabedersen 61 inhibits protein synthesis 61 rituximab 61 idebenone 61 differentiated thyroid 61 Olaparib 61 BANZEL 61 Perifosine 61 ximelagatran 61 cisplatin resistant 61 Lung Cancer Drug 61 Statistically Significant 61 H pylori 61 alpha blocker 61 adefovir dipivoxil 61 TNF inhibitors 61 Previously Treated 61 chronic eosinophilic leukemia 61 selective agonist 61 Kinoid 61 cabazitaxel 61 Revlimid lenalidomide 61 DNA intercalator 61 angiotensin II receptor blocker 61 Salmeterol 61 Teriparatide 61 nonnucleoside reverse transcriptase inhibitors 61 irbesartan 61 Syk 61 fluvastatin 61 BRAF mutation 61 DPP4 61 Complicated Skin 61 Amrubicin 61 Combination Treatment 61 anti CD3 61 Phase 2b Study 61 insulin sensitizers 61 antiplatelet agent 61 galantamine 61 TKI therapy 61 metastatic kidney 61 Sutent sunitinib 61 Carfilzomib 61 Abiraterone 61 Investigational Treatment 61 cetuximab Erbitux 61 Hepatocellular Carcinoma HCC 61 Taxol paclitaxel 61 poly ADP ribose polymerase 61 trabectedin 61 VEGF inhibitors 61 Fixed Dose 61 TACE 61 Ozarelix 61 Glucocorticoids 61 histone deacetylase inhibitors 61 Fludara 61 Amiodarone 61 Newly Diagnosed Multiple Myeloma 61 Romiplostim 61 hedgehog pathway 61 5 HT6 receptor 61 pegylated 61 endoxifen 61 direct thrombin inhibitors 61 cyclosporin 61 Rofecoxib 61 Cladribine 61 Catena ® 61 Low Dose 61 Oral Fingolimod 61 Novel Mechanism 61 MDM2 61 ceftriaxone 61 Aortic Stenosis 61 fibrinolytic 61 Daptomycin 61 APTIVUS 61 Darusentan 61 Tasimelteon 61 Elotuzumab 61 gamma secretase inhibitor 61 Metastatic Prostate Cancer 61 antisense oligonucleotide 61 Cannabinoid 61 ErbB2 positive 61 chronic lymphocytic leukemia CLL 61 Tanespimycin 61 amphotericin B 61 JAK Inhibitor 61 basiliximab 61 nephrotoxicity 61 benazepril 61 gastrointestinal stromal tumor GIST 61 Soft Tissue Sarcoma 61 Plus Ribavirin 61 Bivalirudin 61 abacavir Ziagen 61 amprenavir 61 Ceftaroline 61 VFEND 61 Avastin bevacizumab 61 lumiliximab 61 Neulasta ® 61 lapatinib 61 cardiotoxic 61 immunomodulatory therapy 61 MULTAQ 61 chronic myeloid leukemia CML 61 Levofloxacin 61 Seliciclib 61 MEK ERK 61 idraparinux 61 antifibrotic 61 Campath alemtuzumab 61 thymidylate synthase 61 integrase inhibitor 61 FGFR1 61 5alpha reductase 61 EGF receptor 61 Tyrima 61 Peginterferon alfa 2b 61 SPC# [001] 61 Sunitinib 61 Deforolimus 61 nucleotide analogs 61 Entecavir 61 Hsp# Inhibitor 61 rifamycins 61 Pathway Inhibitor 61 trastuzumab Herceptin 61 insulin sensitizing 61 Elagolix 61 Corticosteroid 61 Allergic Rhinitis 61 Monoclonal Antibody 61 LHRH agonist 61 gastrointestinal stromal tumors GISTs 61 Demonstrates Potent 61 L dopa 61 Drug Candidate 61 bcl 2 61 leflunomide 61 Perindopril 61 hypereosinophilic syndrome 61 alpha 2a 61 angiogenesis inhibition 61 gefitinib 61 peginterferon 61 LHRH agonists 61 Phase III Clinical Trial 61 phosphodiesterase type 5 61 humanized anti 61 ERK pathway 61 Etravirine 61 Hepatocellular Carcinoma 61 BRAF gene 61 Ranolazine 61 Vfend 61 Sanofi Aventis Taxotere 61 demethylating agent 61 CDDO Im 61 Glatiramer Acetate 61 Ramipril 61 neurotrophic factor 61 PRT# 61 Immunotherapy 61 sunitinib Sutent 61 chronic myelogenous leukemia CML 61 CYP#A# substrate 61 Septic Shock 60 BRAF inhibitor 60 oxcarbazepine 60 SPRYCEL ® 60 Azathioprine 60 Clinical Trial Results 60 TNF α 60 Cilostazol 60 mecamylamine 60 p# activation 60 Bavituximab 60 androgen receptor AR 60 Donepezil 60 TPMT 60 infliximab Remicade 60 metastatic colorectal 60 trimethoprim sulfamethoxazole 60 Potent Inhibitor 60 indinavir 60 Ziprasidone 60 KRAS mutation 60 Pafuramidine 60 Maraviroc 60 malignant ascites 60 calcineurin inhibitor 60 oral JAK1 60 atypical hemolytic uremic syndrome 60 #ME# 60 MAGE A3 ASCI 60 Antitumor 60 Thromboembolism 60 CYP3A 60 Cell Lymphoma CTCL 60 Tolerability 60 Rapamycin 60 liposomal formulation 60 Copegus ribavirin 60 IGF 1R 60 vWD 60 Mesenchymal 60 CBLC# 60 humanized monoclonal 60 Survival Benefit 60 trastuzumab Herceptin ® 60 FUS1 60 Phase 2b Clinical Trial 60 Metastatic Renal Cell Carcinoma 60 TNF Alpha 60 Atypical Hemolytic Uremic Syndrome 60 Angiogenic 60 Enalapril 60 JAK inhibitors 60 Glufosfamide 60 CCX# 60 Amphotericin B 60 proteasome inhibitor bortezomib 60 Fabry Disease 60 inhibit replication 60 tenofovir DF 60 ceftazidime 60 Cytotoxicity 60 selectively inhibited 60 ImClone Erbitux 60 Isoniazid 60 Vaprisol 60 masitinib 60 talabostat 60 Paclitaxel 60 Advanced Renal Cell 60 LMWH 60 icatibant 60 Advagraf 60 inhibitor RG# 60 Gleevec Glivec 60 Roche Actemra 60 Mantle Cell Lymphoma 60 Dabigatran 60 RANKL 60 Systemic Delivery 60 ribavirin RBV 60 Radiofrequency Ablation RFA 60 dexrazoxane 60 factor TNF 60 targeting CD# 60 interferon beta 60 CD# monoclonal antibody 60 Anidulafungin 60 Rasagiline 60 Taxotere docetaxel 60 nucleoside 60 sorafenib 60 PI3K inhibitor 60 amikacin 60 relapsed SCLC 60 Pegylated Liposomal Doxorubicin 60 Valopicitabine 60 galiximab 60 Kinase Inhibitors 60 docetaxel Taxotere ® 60 daunorubicin 60 Daclizumab 60 Angiotensin Converting Enzyme 60 HSP# inhibitor 60 targeted antifolate 60 vinca alkaloid 60 Anticancer Agent 60 endothelin receptor antagonists 60 COX2 60 CYP #A# 60 MEK1 60 anti androgen 60 lung fibrosis 60 chemotherapeutic regimen 60 Improves Survival 60 kinase inhibitor 60 Lisofylline 60 pegylated interferon alpha 60 panobinostat 60 Ridaforolimus 60 MabCampath 60 pegylated interferon alfa 60 Progressive Multifocal Leukoencephalopathy 60 multidrug resistance 60 metastatic RCC 60 eflornithine 60 Potent Anti 60 colorectal carcinoma 60 protein tyrosine phosphatase 1B 60 PARP inhibitor 60 mTOR mammalian target 60 Clindamycin 60 Malignant Glioma 60 uricase 60 Angiotensin II 60 Allergic Asthma 60 HoFH 60 antimetabolite 60 HCV protease 60 Riluzole 60 Recombinant Human 60 Lubiprostone 60 Glivec imatinib 60 Nexavar ® 60 Omalizumab 60 Antifungals 60 Bcl xL 60 methylene blue 60 HDACi 60 signal transduction inhibitor 60 chemoresistance 60 arsenic trioxide 60 Calcitonin 60 tretinoin 60 anti angiogenic therapies 60 Relapsing Multiple Sclerosis 60 azole 60 HuMax CD# 60 microglial activation 60 quinolone 60 oral antiviral 60 benzimidazole 60 leukemic stem cells 60 Vicriviroc 60 taxane chemotherapy 60 Panzem R NCD 60 ULORIC 60 delafloxacin 60 PTP 1B 60 Dronedarone 60 Peginterferon Alfa 2a 60 Amikacin 60 chemo resistant 60 nelfinavir 60 Mutational 60 antiandrogen 60 Hodgkin lymphoma NHL 60 novel VDA molecule 60 glatiramer acetate 60 E#F# 60 adriamycin 60 VIDAZA 60 topoisomerase 60 ciclosporin 60 tafamidis 60 gonadotrophin releasing hormone GnRH 60 Helicobacter pylori H. pylori 60 Treating Chronic 60 invasive candidiasis 60 raltegravir 60 refractory chronic myeloid 60 Letairis ambrisentan 60 Severe Sepsis 60 BARACLUDE ® 60 Adefovir 60 Notch1 60 beta adrenergic 60 Certolizumab 60 Unresectable 60 Rifampicin 60 BYSTOLIC 60 HER2 positive metastatic breast 60 HCV replication 60 Metronidazole 60 Mesenchymal Stem Cells 60 anidulafungin 60 Benign Prostatic Hyperplasia 60 Cell Lymphoma 60 Progenitor Cells 60 Ceflatonin 60 sulfasalazine 60 leukemia CLL 60 Hepatocytes 60 vemurafenib 60 Omnitarg 60 Indacaterol 60 Cytoxan 60 eplerenone 60 tolvaptan 60 receptor antagonists 60 PDGF receptor 60 antitumor effect 60 interferon ribavirin 60 denileukin diftitox 60 Pirfenidone 60 MCyR 60 fluorouracil 60 Immunomodulatory 60 dose cytarabine 60 ISF# 60 cefuroxime 60 N acetylcysteine 60 seliciclib 60 statin simvastatin 60 Oral Mucositis 60 Taxotere ® 60 flecainide 60 Ustekinumab 60 nicotinic acid 60 Selective Inhibitor 60 LT NS# 60 Phase 2a Clinical Trial 60 ALK inhibitor 60 PDE# 60 Hypotension 60 APTIVUS R 60 proto oncogene 60 Antifungal 60 Hycamtin ® 60 forskolin 60 Androgen 60 Polymerase Inhibitor 60 antiangiogenic agent 60 histone deacetylase HDAC inhibitor 60 COPAXONE R 60 Glioblastoma Multiforme 60 glitazone 60 Etoposide 60 Idiopathic Pulmonary Fibrosis 60 prednisone prednisolone 60 standard chemotherapy regimen 60 BH4 60 HuMax CD4 60 Tarceva erlotinib 60 B7 H3 60 vandetanib 60 Valdoxan 60 myeloma cells 60 Placebo Controlled Study 60 Pamidronate 60 receptor modulators 60 reperfusion injury 60 Chronic Myelogenous Leukemia 60 plasma kallikrein inhibitor 60 Interferon Alpha 60 Valproate 60 Methicillin 60 Tasigna nilotinib 60 Immunosuppressant 60 Neuvenge 60 EGFR inhibitor 60 Anticancer Activity 60 clusterin 60 Gleevac 60 tiuxetan 60 Aviptadil 60 parthenolide 60 Solid Tumors 60 Levetiracetam 60 BEXXAR Therapeutic Regimen 60 Taxane 60 cytotoxic chemotherapy 60 novel peptide 60 etanercept Enbrel 60 Hematopoietic 60 voriconazole 60 Saquinavir